Development of Foxy-5 as a first in class anti-metastatic cancer drug
Foxy-5 is a small peptide that mimics the effects of the protein Wnt-5a. Foxy-5 inhibits the development of metastasis and thereby increase survival rates in patients with breast and in particular colorectal cancer. Tumour metastasis is the predominant cause of death among cancer patients.
6 098 360.00€